What is she best known for?
The fields of study she is best known for:
Her primary areas of investigation include Biochemistry, Transferrin, Cell biology, Hepcidin and Transferrin receptor.
Her studies examine the connections between Biochemistry and genetics, as well as such issues in Mononuclear phagocyte system, with regards to Metabolism, Phagocytosis and Erythrophagocytosis.
Her Transferrin research integrates issues from Hemochromatosis, Extracellular and Ferritin.
Particularly relevant to Endosome is her body of work in Cell biology.
Her work investigates the relationship between Hepcidin and topics such as Homeostasis that intersect with problems in Anemia of chronic disease and Anemia.
Her Transferrin receptor research includes themes of Saccharomyces cerevisiae Proteins and Iron deficiency.
Her most cited work include:
- Chemistry and biology of eukaryotic iron metabolism. (565 citations)
- Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin (395 citations)
- Iron Metabolism in the Reticuloendothelial System (273 citations)
What are the main themes of her work throughout her whole career to date?
Marianne Wessling-Resnick focuses on Biochemistry, Cell biology, Transferrin, Endocrinology and Internal medicine.
Her Biochemistry study incorporates themes from Hemochromatosis and Hepcidin.
Her study looks at the relationship between Cell biology and fields such as Endocytic cycle, as well as how they intersect with chemical problems.
Her Transferrin research is mostly focused on the topic Transferrin receptor.
Her research in Endocrinology intersects with topics in Hereditary hemochromatosis, Manganese and Iron deficiency.
Marianne Wessling-Resnick has researched Internal medicine in several fields, including Genetic model and In vivo.
She most often published in these fields:
- Biochemistry (38.06%)
- Cell biology (29.10%)
- Transferrin (20.90%)
What were the highlights of her more recent work (between 2012-2020)?
- Hepcidin (16.42%)
- Cell biology (29.10%)
- Endocrinology (20.15%)
In recent papers she was focusing on the following fields of study:
Marianne Wessling-Resnick mainly focuses on Hepcidin, Cell biology, Endocrinology, Internal medicine and DMT1.
Marianne Wessling-Resnick interconnects Genistein, Transferrin saturation, Small molecule, Micronutrient and STAT3 in the investigation of issues within Hepcidin.
Her research integrates issues of Caspase 12, Microglia, Neuroinflammation, Transferrin receptor and In vivo in her study of Cell biology.
Her biological study spans a wide range of topics, including Hereditary hemochromatosis, Genetic model and Anemia.
Her DMT1 study combines topics in areas such as Iron transport, Transferrin and Iron uptake.
Her Biochemistry study frequently draws connections to other fields, such as Hemochromatosis.
Between 2012 and 2020, her most popular works were:
- Iron and mechanisms of emotional behavior (90 citations)
- Nramp1 and Other Transporters Involved in Metal Withholding during Infection (68 citations)
- Inflammation-induced Iron Transport and Metabolism by Brain Microglia (53 citations)
In her most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Iron deficiency, Cell biology, DMT1, Transporter and Neuroinflammation.
Her work carried out in the field of Iron deficiency brings together such families of science as Caspase 3, Oxidative stress, Glucose-regulated protein, Caspase 12 and Neurotransmitter.
Her studies deal with areas such as Transferrin receptor and Apoptosis, Programmed cell death as well as Cell biology.
Her DMT1 research is classified as research in Biochemistry.
While working in this field, Marianne Wessling-Resnick studies both Biochemistry and Hinokitiol.
Her study explores the link between Neuroinflammation and topics such as Microglia that cross with problems in Secretion, Neurodegeneration, Transferrin and Ferritin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
